Published: 22nd August, 2018
Trial aims to identify breath biomarkers to improve the early detection and diagnosis of different cancer types.
Owlstone Medical, a diagnostics company developing a breathalyzer for disease, will run the PAN Cancer trial for Early Detection of Cancer in Breath. The large scale clinical study will evaluate the use of Owlstone Medical’s Breath Biopsy® platform for the early detection of multiple cancer types.
Published: 01st August, 2018
New study reveals that it is possible to identify people at high risk of developing Acute Myeloid Leukaemia (AML) years before they became ill.
Published: 30th July, 2018
Successful application to Rosetrees Trust Interdisciplinary Prize 2018 for non-invasive diagnostic test for renal cell cancers at point of care.
Published: 16th July, 2018
The International Cell Senescence Association (ICSA) conference 2018 took place from July 8th-11th in Montreal, Canada and was attended by members of the Munoz-Espin lab. Estela Gonzalez-Gualda, PhD student in the lab, was awarded a poster prize at the conference. Many congratulations Estela.
Published: 03rd July, 2018
Mr Vincent Gnanapragasam and Professor Andrew Flewitt featured on the BBC Look East Evening News of 2 July 2018. They have both been working on new devices to improve accuracy in prostate cancer detection. The coverage shows both tools, the CamProbe and the FBAR which should be safer and more accurate than the current PSA test.
Published: 06th June, 2018
Sorex Sensors, a spin-out from the University of Cambridge Department of Engineering has secured an initial round of investment from Cambridge Enterprise, Cambridge Angels and Cambridge Capital Group. The Film Bulk Acoustic Resonator (FBAR) technology has many applications including in cancer detection. One of these applications in prostate cancer detection was investigated by Professor Flewitt and his team with funding from a CRUK Cambridge Centre Early Detection Programme pump-priming award.
Published: 22nd May, 2018
In a speech by Teresa May the Government has pledged millions of pounds of funding to develop artificial intelligence able to transform outcomes through early diagnosis of cancer and chronic disease through the Industrial Strategy Grand Challenges.
Industry and charities will work with the NHS to develop algorithms that can use patient data and lifestyle information to warn GPs when a patient should be referred to an oncologist or another specialist. It is estimated that AI could help prevent 22,000 deaths from cancer each year by 2033, and give patients an additional five years of healthy, independent life by 2035.
Published: 21st May, 2018
Dr Stephen John, Senior Lecturer in Philosophy of Public Health, Cambridge University has written about the ethical issues surrounding the recent news that IT errors resulted in women not being invited to their final breast screening appointment. He asks: 'Was anyone harmed by the breast cancer screening scandal?' In this balanced analysis Stephen argues that it all depends which direction you look in - read here
Published: 08th May, 2018
In order to facilitate applications to their new funding schemes that require inter-institutional and multidisciplinary collaborations, CRUK have developed a "Collaboration Matcher". We would like to see much more representation from Cambridge researchers and encourage you to complete the simple form here, outlining your early detection research interests and your collaboration needs. The responses will be made available immediately to other early detection researchers.
Published: 25th April, 2018
Dr Juliet Usher-Smith, academic general practitioner from the Primary Care Unit (PCU) and member of our programme, has been awarded a grant of almost £65,000 from Bowel Cancer UK and Beating Bowel Cancer. The research will investigate whether people living in England should be invited to take part in the bowel cancer screening programme based on their genes and lifestyle factors, not just based on their age.